In early 2015, the Centers for Medicare & Medicaid Services (CMS) initiated reimbursement for low-dose computed tomography (LDCT) screening for lung cancer in individuals aged 55 to 77 years with a 30 pack-year or greater smoking history.1 A unique feature of the CMS approval was a requirement for a separate shared decision-making (SDM) session before the LDCT.1 This visit had several required components, including use of a decision aid and counseling on tobacco abstinence. We used Medicare data from January 1, 2015, through December 31, 2016 to determine the percentage of enrollees who received an LDCT had a visit for SDM.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Goodwin JS, Nishi S, Zhou J, Kuo Y. Use of the Shared Decision-Making Visit for Lung Cancer Screening Among Medicare Enrollees. JAMA Intern Med. Published online January 14, 2019. doi:10.1001/jamainternmed.2018.6405
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: